Studies suggest that rTMS may regulate the sleep–wake system by reducing cortical excitability, modulating neurotransmitter activity (such as GABA, 5-HT, and BDNF) and increasing cerebral blood flow, thereby improving sleep quality in stroke patients with sleep disorders (22, 23). The gene discussed is BDNF; the disease is stroke disorder.